HERON THERAPEUTICS, INC. /DE/ Available-for-sale Securities
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Available-for-sale Securities of $67.36 million as of 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2018-05-10
- 2018-03-31: Available-for-sale Securities $67.36M.
- 2017-12-31: Available-for-sale Securities $27.80M.
- 2017-09-30: Available-for-sale Securities $8.49M.
- 2017-06-30: Available-for-sale Securities $83.98M.
| Period end | Available-for-sale Securities |
|---|---|
| 2018-03-31 | $67.36M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $27.80M 10-Q · filed 2018-05-10 |
| 2017-09-30 | $8.49M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $83.98M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $122.12M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $37.72M 10-Q · filed 2017-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |